|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J
and Sung JJ: Dysregulation of cellular signaling in gastric cancer.
Cancer Lett. 295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Venerito M, Nardone G, Selgrad M, Rokkas T
and Malfertheiner P: Gastric cancer - epidemiologic and clinical
aspects. Helicobacter. 19(Suppl 1): 32–37. 2014. View Article : Google Scholar
|
|
5
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong HW, Zhang S, Sun WG, Liu Q, Ibla JC,
Soriano SG, Han XH, Liu LX, Li MS and Liu JR: β-ionone arrests cell
cycle of gastric carcinoma cancer cells by a MAPK pathway. Arch
Toxicol. 87:1797–1808. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen P, Zhao D, Sun Y, Huang L, Zhang S
and Yuan Y: Protein inhibitor of activated STAT-1 is downregulated
in gastric cancer tissue and involved in cell metastasis. Oncol
Rep. 28:2149–2155. 2012.PubMed/NCBI
|
|
8
|
Chen L, Hu W, Tan S, Wang M, Ma Z, Zhou S,
Deng X, Zhang Y, Huang C, Yang G, et al: Genome-wide identification
and analysis of MAPK and MAPKK gene families in Brachypodium
distachyon. PLoS One. 7:e467442012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berlier JL, Rigutto S, Dalla Valle A,
Lechanteur J, Soyfoo MS, Gangji V and Rasschaert J: Adenosine
triphosphate prevents serum deprivation-induced apoptosis in human
mesenchymal stem cells via activation of the MAPK signaling
pathways. Stem Cells. 33:211–218. 2015. View Article : Google Scholar
|
|
10
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Z, Cai Y, Zhang W, Liu X and Liu S:
Astragaloside IV inhibits platelet-derived growth
factor-BB-stimulated proliferation and migration of vascular smooth
muscle cells via the inhibition of p38 MAPK signaling. Exp Ther
Med. 8:1253–1258. 2014.PubMed/NCBI
|
|
12
|
Bernardo-Faura M, Massen S, Falk CS, Brady
NR and Eils R: Data-derived modeling characterizes plasticity of
MAPK signaling in melanoma. PLoS Comput Biol. 10:e10037952014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park GB, Choi Y, Kim YS, Lee HK, Kim D and
Hur DY: ROS-mediated JNK/p38-MAPK activation regulates Bax
translocation in sorafenib-induced apoptosis of EBV-transformed B
cells. Int J Oncol. 44:977–985. 2014.PubMed/NCBI
|
|
14
|
Favata MF, Horiuchi KY, Manos EJ, Daulerio
AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F,
et al: Identification of a novel inhibitor of mitogen-activated
protein kinase kinase. J Biol Chem. 273:18623–18632. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caunt CJ and Keyse SM: Dual-specificity
MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase
signalling. FEBS J. 280:489–504. 2013. View Article : Google Scholar :
|
|
16
|
Wu GS: Role of mitogen-activated protein
kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev.
26:579–585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Keyse SM: Dual-specificity MAP kinase
phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27:253–261.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muda M, Boschert U, Smith A, Antonsson B,
Gillieron C, Chabert C, Camps M, Martinou I, Ashworth A and
Arkinstall S: Molecular cloning and functional characterization of
a novel mitogen-activated protein kinase phosphatase, MKP-4. J Biol
Chem. 272:5141–5151. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Lagowski J, Sundholm A, Sundberg A
and Kulesz-Martin M: Microtubule disruption and tumor suppression
by mitogen-activated protein kinase phosphatase 4. Cancer Res.
67:10711–10719. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu S, Wang Y, Sun L, Zhang Z, Jiang Z, Qin
Z, Han H, Liu Z, Li X, Tang A, et al: Decreased expression of
dual-specificity phosphatase 9 is associated with poor prognosis in
clear cell renal cell carcinoma. BMC Cancer. 11:4132011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu J, Ni W, Xiao M, Jiang F and Ni R:
Decreased expression and prognostic role of mitogen-activated
protein kinase phosphatase 4 in hepatocellular carcinoma. J
Gastrointest Surg. 17:756–765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jenner S, Wiedorn KH and Techel D:
Development of a DUSP9 methylation screening assay. Pathol Oncol
Res. 21:123–130. 2015. View Article : Google Scholar
|
|
23
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: a fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar
|
|
25
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Palau A, Perucho M, Esteller M and
Buschbeck M: First Barcelona conference on epigenetics and cancer.
Epigenetics. 9:468–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu G, Liu YJ, Lian WJ, Zhao ZW, Yi T and
Zhou HY: Reduced BMP6 expression by DNA methylation contributes to
EMT and drug resistance in breast cancer cells. Oncol Rep.
32:581–588. 2014.PubMed/NCBI
|
|
28
|
Minning C, Mokhtar NM, Abdullah N,
Muhammad R, Emran NA, Ali SA, Harun R and Jamal R: Exploring breast
carcinogenesis through integrative genomics and epigenomics
analyses. Int J Oncol. 45:1959–1968. 2014.PubMed/NCBI
|
|
29
|
Vizoso M and Esteller M: German-Catalan
workshop on epigenetics and cancer. Epigenetics. 8:998–1003. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guerrero-Preston R, Hadar T, Ostrow KL,
Soudry E, Echenique M, Ili-Gangas C, Pérez G, Perez J,
Brebi-Mieville P, Deschamps J, et al: Differential promoter
methylation of kinesin family member 1a in plasma is associated
with breast cancer and DNA repair capacity. Oncol Rep. 32:505–512.
2014.PubMed/NCBI
|
